Antimicrobial Effects of Biogenic Nanoparticles

Priyanka Singh, Abhroop Garg, Santosh Pandit, V. R. S. S. Mokkapati, Ivan Mijakovic*

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

140 Downloads (Pure)

Abstract

Infectious diseases pose one of the greatest health challenges in the medical world. Though numerous antimicrobial drugs are commercially available, they often lack effectiveness against recently developed multidrug resistant (MDR) microorganisms. This results in high antibiotic dose administration and a need to develop new antibiotics, which in turn requires time, money, and labor investments. Recently, biogenic metallic nanoparticles have proven their effectiveness against MDR microorganisms, individually and in synergy with the current/conventional antibiotics. Importantly, biogenic nanoparticles are easy to produce, facile, biocompatible, and environmentally friendly in nature. In addition, biogenic nanoparticles are surrounded by capping layers, which provide them with biocompatibility and long-term stability. Moreover, these capping layers provide an active surface for interaction with biological components, facilitated by free active surface functional groups. These groups are available for modification, such as conjugation with antimicrobial drugs, genes, and peptides, in order to enhance their efficacy and delivery. This review summarizes the conventional antibiotic treatments and highlights the benefits of using nanoparticles in combating infectious diseases.
Original languageEnglish
Article number1009
JournalNanomaterials
Volume8
Issue number12
Number of pages19
ISSN2079-4991
DOIs
Publication statusPublished - 2018

Keywords

  • Antibiotics
  • Nanoparticles
  • Biogenic nanoparticles
  • Antimicrobial
  • Antibiotic resistance
  • Multidrug resistant (MDR) microorganisms

Cite this

Singh, Priyanka ; Garg, Abhroop ; Pandit, Santosh ; Mokkapati, V. R. S. S. ; Mijakovic, Ivan. / Antimicrobial Effects of Biogenic Nanoparticles. In: Nanomaterials. 2018 ; Vol. 8, No. 12.
@article{1eaa5d50995146b0946df4317b8d5226,
title = "Antimicrobial Effects of Biogenic Nanoparticles",
abstract = "Infectious diseases pose one of the greatest health challenges in the medical world. Though numerous antimicrobial drugs are commercially available, they often lack effectiveness against recently developed multidrug resistant (MDR) microorganisms. This results in high antibiotic dose administration and a need to develop new antibiotics, which in turn requires time, money, and labor investments. Recently, biogenic metallic nanoparticles have proven their effectiveness against MDR microorganisms, individually and in synergy with the current/conventional antibiotics. Importantly, biogenic nanoparticles are easy to produce, facile, biocompatible, and environmentally friendly in nature. In addition, biogenic nanoparticles are surrounded by capping layers, which provide them with biocompatibility and long-term stability. Moreover, these capping layers provide an active surface for interaction with biological components, facilitated by free active surface functional groups. These groups are available for modification, such as conjugation with antimicrobial drugs, genes, and peptides, in order to enhance their efficacy and delivery. This review summarizes the conventional antibiotic treatments and highlights the benefits of using nanoparticles in combating infectious diseases.",
keywords = "Antibiotics, Nanoparticles, Biogenic nanoparticles, Antimicrobial, Antibiotic resistance, Multidrug resistant (MDR) microorganisms",
author = "Priyanka Singh and Abhroop Garg and Santosh Pandit and Mokkapati, {V. R. S. S.} and Ivan Mijakovic",
year = "2018",
doi = "10.3390/nano8121009",
language = "English",
volume = "8",
journal = "Nanomaterials",
issn = "2079-4991",
publisher = "M D P I AG",
number = "12",

}

Antimicrobial Effects of Biogenic Nanoparticles. / Singh, Priyanka; Garg, Abhroop; Pandit, Santosh; Mokkapati, V. R. S. S.; Mijakovic, Ivan.

In: Nanomaterials, Vol. 8, No. 12, 1009, 2018.

Research output: Contribution to journalJournal articleResearchpeer-review

TY - JOUR

T1 - Antimicrobial Effects of Biogenic Nanoparticles

AU - Singh, Priyanka

AU - Garg, Abhroop

AU - Pandit, Santosh

AU - Mokkapati, V. R. S. S.

AU - Mijakovic, Ivan

PY - 2018

Y1 - 2018

N2 - Infectious diseases pose one of the greatest health challenges in the medical world. Though numerous antimicrobial drugs are commercially available, they often lack effectiveness against recently developed multidrug resistant (MDR) microorganisms. This results in high antibiotic dose administration and a need to develop new antibiotics, which in turn requires time, money, and labor investments. Recently, biogenic metallic nanoparticles have proven their effectiveness against MDR microorganisms, individually and in synergy with the current/conventional antibiotics. Importantly, biogenic nanoparticles are easy to produce, facile, biocompatible, and environmentally friendly in nature. In addition, biogenic nanoparticles are surrounded by capping layers, which provide them with biocompatibility and long-term stability. Moreover, these capping layers provide an active surface for interaction with biological components, facilitated by free active surface functional groups. These groups are available for modification, such as conjugation with antimicrobial drugs, genes, and peptides, in order to enhance their efficacy and delivery. This review summarizes the conventional antibiotic treatments and highlights the benefits of using nanoparticles in combating infectious diseases.

AB - Infectious diseases pose one of the greatest health challenges in the medical world. Though numerous antimicrobial drugs are commercially available, they often lack effectiveness against recently developed multidrug resistant (MDR) microorganisms. This results in high antibiotic dose administration and a need to develop new antibiotics, which in turn requires time, money, and labor investments. Recently, biogenic metallic nanoparticles have proven their effectiveness against MDR microorganisms, individually and in synergy with the current/conventional antibiotics. Importantly, biogenic nanoparticles are easy to produce, facile, biocompatible, and environmentally friendly in nature. In addition, biogenic nanoparticles are surrounded by capping layers, which provide them with biocompatibility and long-term stability. Moreover, these capping layers provide an active surface for interaction with biological components, facilitated by free active surface functional groups. These groups are available for modification, such as conjugation with antimicrobial drugs, genes, and peptides, in order to enhance their efficacy and delivery. This review summarizes the conventional antibiotic treatments and highlights the benefits of using nanoparticles in combating infectious diseases.

KW - Antibiotics

KW - Nanoparticles

KW - Biogenic nanoparticles

KW - Antimicrobial

KW - Antibiotic resistance

KW - Multidrug resistant (MDR) microorganisms

U2 - 10.3390/nano8121009

DO - 10.3390/nano8121009

M3 - Journal article

VL - 8

JO - Nanomaterials

JF - Nanomaterials

SN - 2079-4991

IS - 12

M1 - 1009

ER -